Related Experiment Videos
Nitric oxide dependent vasodilation in young spontaneously hypertensive rats
A Radaelli1, L Mircoli, I Mori
1Centro di Fisiologia Clinica e Ipertensione, Cattedra di Cardioangiologia Medica, Università di Milano, Ospedale Maggiore, Milano, Italy. alberto.ferrari@unimi.it
Hypertension (Dallas, Tex. : 1979)
|October 17, 1998
Summary
Nitric oxide (NO) mediated vasodilation is preserved, not impaired, in early hypertension. This suggests NO function is not a key factor in developing hypertension in spontaneously hypertensive rats.
Area of Science:
- Cardiovascular Physiology
- Renal Physiology
- Pharmacology
Background:
- Conflicting evidence exists regarding the role of nitric oxide (NO)-mediated vasodilation impairment in hypertension.
- Understanding NO's role is crucial for identifying hypertension's pathogenic mechanisms.
- This study investigates NO-dependent vasodilation in early hypertension using a rat model.
Purpose of the Study:
- To evaluate tonic NO-dependent vasodilation in spontaneously hypertensive rats (SHR) during early established hypertension.
- To assess the contribution of impaired NO-mediated vasodilation to hypertension development.
- To compare NO-dependent and independent pressor responses between SHR and Wistar-Kyoto rats (WKY).
Main Methods:
- Conscious, instrumented SHR and WKY rats (12 weeks old) were used.
- NO synthesis was inhibited using NG-monomethyl-L-arginine (L-NMMA).
- Pressor responses to L-NMMA, vasopressin, and phenylephrine were measured under control and autonomic reflex-suppressed conditions (hexamethonium).
Main Results:
- Pressor responses to L-NMMA were significantly larger in SHR compared to WKY rats, both under control (39%) and areflexic (71%) conditions.
- Responses to non-NO-dependent stimuli (vasopressin and phenylephrine) were also enhanced in SHR.
- In prehypertensive SHR (6 weeks old), responses to L-NMMA and other stimuli were similar between SHR and WKY rats.
Conclusions:
- NO-dependent vasodilation is preserved, and potentially enhanced, during the early stages of hypertension in SHR.
- Impaired NO-mediated vasodilation does not appear to be a significant pathogenic factor in the onset of hypertension in this model.
- These findings challenge the hypothesis that reduced NO bioavailability contributes to hypertension development in SHR.